Mannin Research is a biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular related diseases using the Tie2 mechanism of action. Mannin’s Tie2 platform technology addresses a number of vascular related diseases. Mannin is currently developing host-directed therapeutics to treat Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients.
Looking for a particular Mannin Research employee's phone or email?
Mannin Research Questions
The Mannin Research annual revenue was $1 million in 2026.
George Nikopoulos is the President and CEO of Mannin Research.
7 people are employed at Mannin Research.
Mannin Research is based in Toronto, Ontario.
The NAICS codes for Mannin Research are [541, 541714, 5417, 54171, 54].
The SIC codes for Mannin Research are [873, 87].
Top Mannin Research Employees
-
George Nikopoulos
President and CEO at Mannin Research
Toronto, ON, CA1 -
Anil Chawla
Chief Financial Officer at Mannin Research
Mississauga, ON, CA24 -
Michael Ryczko
Preclinical Research Director at Mannin Research
Toronto, ON, CA2 -
Christopher Smith
Executive Chairman at Mannin Research
Toronto, ON, CA2 -
11
-
Norman Yau
Research And Development Scientist at Mannin Research
Toronto, ON, CA1
Related Companies
